Search research articles
Contact Us
Filters
Showing results (1-10 of 176) with videos related to
Page
of 18
Sort By:
Postgraduate Medical Journal
|
December 2, 2015
Superiority trials: statistical trickery or mass blindness?
Nusrat Shafiq, Samir Malhotra
Evidence-Based Medicine
|
September 5, 2015
Superiority trials: raising the bar of null hypothesis statistical testing
Nusrat Shafiq, Samir Malhotra
Contemporary Clinical Trials
|
December 15, 2010
Ethics in clinical research: need for assessing comprehension of informed consent form?
Nusrat Shafiq, Samir Malhotra
Expert Opinion on Pharmacotherapy
|
May 13, 2003
Effect of hormone replacement therapy on cardiovascular disease: current opinion
Nusrat Shafiq Khan, Samir Malhotra
Frontiers in Public Health
|
May 16, 2024
Editorial: Antimicrobial resistance and stewardship in the COVID-19 era
Ashish Kumar Kakkar, Nusrat Shafiq
British Journal of Clinical Pharmacology
|
November 14, 2008
Investigator-initiated pragmatic trials in developing countries--much needed but much ignored
Nusrat Shafiq, Promila Pandhi, Samir Malhotra
BMJ Evidence-Based Medicine
|
January 26, 2018
Effect size in CANTOS trial
Nanda Gamad, Nusrat Shafiq, Samir Malhotra
Indian Dermatology Online Journal
|
February 24, 2022
Severe Cutaneous Adverse Reaction (SCAR): Clinical Pharmacologists' Viewpoint
Nusrat Shafiq, Samiksha Bhattacharjee, Samir Malhotra
Critical Reviews in Therapeutic Drug Carrier Systems
|
April 6, 2012
Drug-loaded PLGA nanoparticles for oral administration: fundamental issues and challenges ahead
Gaurav Kumar, Nusrat Shafiq, Samir Malhotra
Postgraduate Medical Journal
|
March 12, 2020
Meta-analysis of cardiovascular superiority trials published in the <i>New England Journal of Medicine</i> to elucidate the concept of superiority margin
Nanda Gamad, Nusrat Shafiq, Samir Malhotra
Page
of 18
Search research articles
Search
Showing results (1-10 of 176) with videos related to
Sort By:
Page
of 18
Postgraduate Medical Journal
|
December 2, 2015
Superiority trials: statistical trickery or mass blindness?
Nusrat Shafiq, Samir Malhotra
Evidence-Based Medicine
|
September 5, 2015
Superiority trials: raising the bar of null hypothesis statistical testing
Nusrat Shafiq, Samir Malhotra
Contemporary Clinical Trials
|
December 15, 2010
Ethics in clinical research: need for assessing comprehension of informed consent form?
Nusrat Shafiq, Samir Malhotra
Expert Opinion on Pharmacotherapy
|
May 13, 2003
Effect of hormone replacement therapy on cardiovascular disease: current opinion
Nusrat Shafiq Khan, Samir Malhotra
Frontiers in Public Health
|
May 16, 2024
Editorial: Antimicrobial resistance and stewardship in the COVID-19 era
Ashish Kumar Kakkar, Nusrat Shafiq
British Journal of Clinical Pharmacology
|
November 14, 2008
Investigator-initiated pragmatic trials in developing countries--much needed but much ignored
Nusrat Shafiq, Promila Pandhi, Samir Malhotra
BMJ Evidence-Based Medicine
|
January 26, 2018
Effect size in CANTOS trial
Nanda Gamad, Nusrat Shafiq, Samir Malhotra
Indian Dermatology Online Journal
|
February 24, 2022
Severe Cutaneous Adverse Reaction (SCAR): Clinical Pharmacologists' Viewpoint
Nusrat Shafiq, Samiksha Bhattacharjee, Samir Malhotra
Critical Reviews in Therapeutic Drug Carrier Systems
|
April 6, 2012
Drug-loaded PLGA nanoparticles for oral administration: fundamental issues and challenges ahead
Gaurav Kumar, Nusrat Shafiq, Samir Malhotra
Postgraduate Medical Journal
|
March 12, 2020
Meta-analysis of cardiovascular superiority trials published in the <i>New England Journal of Medicine</i> to elucidate the concept of superiority margin
Nanda Gamad, Nusrat Shafiq, Samir Malhotra
Page
of 18